中国政策档案 Governance Archive HOLDINGS 219,011 · FONDS 94
Record · 广东省医疗保障局 ACC. 4263986
医保办发〔2023〕2号

Notice of the Office of the National Healthcare Security Administration on Issuing the Guidelines for Price Formation of COVID-19 Treatment Drugs (Trial)

国家医疗保障局办公室关于印发《新冠治疗药品价格形成指引(试行)》的通知

Issuer
广东省医疗保障局
Date
2023-10-09 17:20:48
Instrument
policy issuance
Cited by
0
This document issues the trial guidelines for price formation of COVID-19 treatment drugs, establishing pricing principles and procedures to regulate drug costs.
Full text · 原文 50 字
国家医保局网站政策文件链接: 国家医疗保障局办公室关于印发《新冠治疗药品价格形成指引(试行)》的通知